American Society for Microbiology, Journal of Clinical Microbiology, 1(44), p. 241-243, 2006
DOI: 10.1128/jcm.44.1.241-243.2006
Full text: Unavailable
ABSTRACT Forty clinical isolates of Enterobacter spp. were identified as extended-spectrum β-lactamase (ESBL) producers by disk diffusion. The VITEK 2 Advanced Expert System (AES) identified the ESBL phenotype in only 25 isolates (62.5%), and erroneously reported cephalosporin susceptibility in 11 isolates (28%). Refinements in the AES are required in order to improve ESBL detection in Enterobacter .